Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host

Metabolic diseases pose a major global health challenge, the pathogenesis of which centers on "metabolic reprogramming"; that is, the adaptive or pathological rewiring of metabolic pathways. Emerging evidence indicates that gut microbiota dysbiosis triggers its metabolic reprogramming prior to host disease onset and plays a pivotal role in the development of metabolic disorders. However, unlike host metabolic reprogramming, which has been well characterized, the pathogenic mechanisms resulting from gut microbiota metabolic reprogramming remain poorly understood, creating a critical knowledge gap regarding its role in systemic metabolic diseases. To address this gap, this review introduces the concept of gut…

• NK
  National Key Research and Development Program of China

  Award: (2024YFC3506304)